US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avidity Biosciences, Inc.

26.68

-0.2300-0.85%

Post-market: 26.680.00000.00%17:07 EDT

Volume:1.20M

Turnover:31.64M

Market Cap:3.21B

PE:-9.24

High:27.67

Open:26.70

Low:25.82

Close:26.91

Loading ...

Overview Company News Filings

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Korro to Participate in Upcoming Investor Conferences

Korro Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency

2 ASX healthcare shares having a stellar run today

Race Oncology Completes Drug Discovery Program at Monash University; Shares Up 3%

MT Newswires Live

Vir Biotechnology Presents Positive Chronic Hepatitis Delta Clinical Trial Data and Announces Initiation of Phase 3 Registrational Program

Silence Therapeutics presents late-breaking Phase 2 zerlasiran data at AHA

BRIEF-Cofactor Genomics Expands Clinical Use Of Oncoprism, As Their AI Enabled RNA Test Achieves National Clinical Validation After Predicting Immunotherapy Response In Lung Cancer Patients

Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics

Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study Data

RNA Stock Hits Record High on Entering the Cardiac Disease Space

Avidity Biosciences (RNA) Gets a Buy from Barclays

Avidity Biosciences Price Target Maintained With a $60.00/Share by Needham

Promising Outlook for Avidity Biosciences: Strategic Focus on Genetic Targeting and Innovative AOC Technology

PYC Therapeutics to Unveil Pioneering RNA Therapy Data

Buy Rating Affirmed for Avidity Biosciences Amid Precision Cardiology Advancements

Avidity Biosciences Announces New Precision Cardiology Development Candidates to Treat Rare Genetic Cardiomyopathies and Provides First Look at Next-Generation Technology Innovations

Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics

Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer Care

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RNA/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNA\",,,,,undefined,":{"symbol":"RNA","market":"US","secType":"STK","nameCN":"Avidity Biosciences, Inc.","latestPrice":26.68,"timestamp":1744747200000,"preClose":26.91,"halted":0,"volume":1196227,"hourTrading":{"tag":"盘后","latestPrice":26.68,"preClose":26.68,"latestTime":"17:07 EDT","volume":161234,"amount":4301723.12,"timestamp":1744751264537},"delay":0,"floatShares":92698253,"shares":120212301,"eps":-2.888476,"marketStatus":"Post-Mkt","change":-0.23,"latestTime":"04-15 19:55:32 EDT","open":26.7,"high":27.67,"low":25.82,"amount":31637145.397561,"amplitude":0.068748,"askPrice":26.75,"askSize":190,"bidPrice":23.69,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.888476,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1744761600000},"marketStatusCode":4,"adr":0,"listingDate":1591934400000,"exchange":"NASDAQ","adjPreClose":26.91,"preHourTrading":{"tag":"盘前","latestPrice":25.23,"preClose":26.91,"latestTime":"08:00 EDT","volume":247,"amount":6550.970061999999,"timestamp":1744718400721},"postHourTrading":{"tag":"盘后","latestPrice":26.68,"preClose":26.68,"latestTime":"17:07 EDT","volume":161234,"amount":4301723.12,"timestamp":1744751264537},"volumeRatio":0.553859,"impliedVol":0.6928,"impliedVolPercentile":0.6135},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNA\",,,,,undefined,":{"symbol":"RNA","floatShares":92698253,"roa":"-21.60%","roe":"-33.47%","lyrEps":-2.888476,"volumeRatio":0.553859,"shares":120212301,"dividePrice":0,"high":27.67,"amplitude":0.068748,"preClose":26.91,"low":25.82,"week52Low":21.51,"pbRate":"2.25","psRate":"294.33","week52High":56,"institutionHeld":0,"latestPrice":26.68,"committee":-0.310345,"eps":-2.888476,"divideRate":0,"volume":1196227,"delay":0,"ttmEps":-2.888476,"open":26.7,"prevYearClose":29.08,"prevWeekClose":25.58,"prevMonthClose":29.52,"prevQuarterClose":29.52,"fiveDayClose":24.08,"twentyDayClose":30.48,"sixtyDayClose":28.92},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RNA\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2485428404","title":"Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2485428404","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485428404?lang=en_us&edition=fundamental","pubTime":"2024-11-22 05:05","pubTimestamp":1732223101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241121:nTUA77C8TP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2210149790.SGD","IE00BKPKM429.USD","BK4139","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4588","BK4112","LU2210150020.SGD","RNA","NDAQ","LU2095319765.USD","BK4505","BK4585","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2485428278","title":"Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2485428278","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485428278?lang=en_us&edition=fundamental","pubTime":"2024-11-22 05:05","pubTimestamp":1732223100,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Nov. 21, 2024 /PRNewswire/ --Avidity Biosciences, Inc. , a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates , today announced that onNovember 20, 2024,the Human Capital Management Committee of Avidity's Board of Directors granted non-qualified stock option awards to purchase an aggregate of 117,000 shares of its common stock and 58,500 restricted stock units  to twelve  new non-executive employees under the Avidity Biosciences, Inc. 2022 Employment Inducement Incentive Award Plan . The awards were granted as inducements material to the employees entering into employment with Avidity in accordance with Nasdaq Listing Rule 5635.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MPQ_41DhqhHuW4qoOGYzoA--~B/aD0xODg7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/d3ba411dafc5b9fe6b77b592275c9c79","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MPQ_41DhqhHuW4qoOGYzoA--~B/aD0xODg7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/d3ba411dafc5b9fe6b77b592275c9c79"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/avidity-biosciences-announces-inducement-grants-210500984.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/avidity-biosciences-announces-inducement-grants-210500984.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2210149790.SGD","IE00B64PRP62.GBP","NDAQ","BK4505","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2095319765.USD","BK4588","BK4139",".IXIC","IE00BGHQF748.EUR","LU2210150020.SGD","RNA","BK4585","BK4112"],"gpt_icon":0},{"id":"2485423662","title":"Korro to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2485423662","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485423662?lang=en_us&edition=fundamental","pubTime":"2024-11-22 05:01","pubTimestamp":1732222860,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Nov.  21, 2024  (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/21/2985602/0/en/Korro-to-Participate-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNA","BK4505","BK4588","BK4585"],"gpt_icon":0},{"id":"2485498833","title":"Korro Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2485498833","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485498833?lang=en_us&edition=fundamental","pubTime":"2024-11-21 20:30","pubTimestamp":1732192200,"startTime":"0","endTime":"0","summary":"-REWRITE study will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple escalating doses of KRRO-110 -First participant dosing anticipated in the first quar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/21/2985116/0/en/Korro-Receives-Australian-HREC-Approval-and-CTN-Clearance-to-Initiate-Phase-1-2a-Clinical-Study-REWRITE-of-KRRO-110-for-Alpha-1-Antitrypsin-Deficiency.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","KRRO","BK4505","BK4139","TGA","BK4213","RNA","BK4588"],"gpt_icon":0},{"id":"2485486986","title":"2 ASX healthcare shares having a stellar run today","url":"https://stock-news.laohu8.com/highlight/detail?id=2485486986","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485486986?lang=en_us&edition=fundamental","pubTime":"2024-11-21 10:52","pubTimestamp":1732157578,"startTime":"0","endTime":"0","summary":"ASX healthcare shares are currently in the red on Thursday, with theS&P/ASX 200 Health Care Index(ASX: XHJ) down 0.2% and the broaderS&P/ASX 200 Index(ASX: XJO) 0.18% lower. However, two ASX healthcar","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/11/21/2-asx-healthcare-shares-having-a-stellar-run-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7508","BK4585","RAC.AU","RNA","BK4139","BK7067","BK4505","BK7103","XJO.AU","SIG.AU","BK4588"],"gpt_icon":0},{"id":"2485107336","title":"Race Oncology Completes Drug Discovery Program at Monash University; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485107336","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485107336?lang=en_us&edition=fundamental","pubTime":"2024-11-21 09:38","pubTimestamp":1732153121,"startTime":"0","endTime":"0","summary":"Race Oncology  completed a drug discovery program targeting the Fat and Obesity associated  protein at Monash University's Fragment Platform, according to a Thursday filing with the Australian bourse.The program used nuclear magnetic resonance screening to identify 39 chemical candidates that bind specifically to the FTO protein, the filing said.The FTO protein is a key regulator in ribonucleic acid  epigenetics. Loss of control of RNA epigenetics is linked to several cancers and metabolic diseases.The identification of the chemical candidates by Race Oncology provides a platform for developing new FTO-targeting drugs, the filing said.Race Oncology plans to advance these candidates into a hit-to-lead medicinal chemistry program, though a final decision has not yet been made on progressing this expensive phase.The company's shares rose almost 3% in recent Thursday trade.Price : $1.40, Change: $+0.04, Percent Change: +2.94%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7067","LU1043141123.HKD","AUD","RNA","BK4505","LU0426417589.USD","LU2238339852.HKD","BK4125","LU0345774631.USD","BK4588","LU0994945656.USD","LU0426412945.USD","BK4139","RAC.AU","BK4585"],"gpt_icon":0},{"id":"2484956973","title":"Vir Biotechnology Presents Positive Chronic Hepatitis Delta Clinical Trial Data and Announces Initiation of Phase 3 Registrational Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2484956973","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484956973?lang=en_us&edition=fundamental","pubTime":"2024-11-19 10:15","pubTimestamp":1731982500,"startTime":"0","endTime":"0","summary":"– Monthly tobevibart and elebsiran combination achieves rapid 100% virologic suppression at Week 24, sustained through Week 60 –。– Undetectable HDV RNA in 41% of participants at Week 24, increasing to 64% by Week 36 and up to 80% by Week 60 across cohorts –。– Combination well-tolerated: no treatment-related severe AEs, treatment-related discontinuations or ALT flares –。– Following a recent FDA meeting, Phase 3 ECLIPSE registrational program to begin in the first half of 2025 –。These data were presented in an oral session at the American Association for the Study of Liver Diseases  The Liver Meeting, in San Diego, CA. Based on these results, and following a recent meeting with the FDA, Vir Biotechnology plans to initiate the Phase 3 registrational ECLIPSE program in the first half of 2025 to further evaluate the combination of tobevibart and elebsiran for the treatment of CHD.Primary Endpoint Analysis from the Phase 2 SOLSTICE Tria","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/l5oi2o6BXS3LWePoIaxyng--~B/aD0yMzM7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/4cd04e41299f5f946a2db3e8d5341040","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/l5oi2o6BXS3LWePoIaxyng--~B/aD0yMzM7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/4cd04e41299f5f946a2db3e8d5341040"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vir-biotechnology-presents-positive-chronic-021500234.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","BK4568","BK4585","LU1878469433.USD","RNA","VIR","CHD","BK4505","BK4504","ALT","BK4079","COMP","BK4535","HDV","BK4588","BK4018","BK4139"],"gpt_icon":0},{"id":"2484198881","title":"Silence Therapeutics presents late-breaking Phase 2 zerlasiran data at AHA","url":"https://stock-news.laohu8.com/highlight/detail?id=2484198881","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484198881?lang=en_us&edition=fundamental","pubTime":"2024-11-19 03:35","pubTimestamp":1731958505,"startTime":"0","endTime":"0","summary":"Silence Therapeutics (SLN) presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a short interfering RNA, or siRNA, in ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/silence-therapeutics-presents-late-breaking-phase-2-zerlasiran-data-at-aha?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/silence-therapeutics-presents-late-breaking-phase-2-zerlasiran-data-at-aha?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLN","LENZ","BK4585","BK4139","BK4505","RNA","BK4588"],"gpt_icon":0},{"id":"2483493371","title":"BRIEF-Cofactor Genomics Expands Clinical Use Of Oncoprism, As Their AI Enabled RNA Test Achieves National Clinical Validation After Predicting Immunotherapy Response In Lung Cancer Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2483493371","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483493371?lang=en_us&edition=fundamental","pubTime":"2024-11-15 22:13","pubTimestamp":1731679981,"startTime":"0","endTime":"0","summary":"Nov 15 (Reuters) -    * COFACTOR GENOMICS EXPANDS CLINICAL USE OF ONCOPRISM, AS THEIR AI ENABLED RNA TEST ACHIEVES NATIONAL CLINICAL VALIDATION AFTER PREDICTING IMMUNOTHERAPY RESPONSE IN LUNG CANCER PATIENTSSource text:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NHLD","RNA"],"gpt_icon":0},{"id":"2483337763","title":"Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2483337763","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483337763?lang=en_us&edition=fundamental","pubTime":"2024-11-15 05:05","pubTimestamp":1731618300,"startTime":"0","endTime":"0","summary":"—Becomes first company to showcase four routes of synthesis for approved siRNA therapeutic asset— —Joint poster with Bachem demonstrates superiority of Company’s double-stranded RNA ligases compared t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/14/2981613/24825/en/Codexis-Unveils-Pioneering-Enzymatic-Synthesis-Data-to-Enable-the-Future-Manufacturing-of-RNAi-Therapeutics.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0997586861.USD","IE00BHPRN162.USD","BK4585","BK4588","BK4144","RNA","CDXS","BK4135","LENZ","ECO","WT","BK4139","BK4121","BK4505"],"gpt_icon":1},{"id":"2483331111","title":"Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2483331111","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483331111?lang=en_us&edition=fundamental","pubTime":"2024-11-15 03:16","pubTimestamp":1731611760,"startTime":"0","endTime":"0","summary":"As the third-quarter earnings season ends this week, the focus in the biotech sector is mostly on pipeline and key regulatory updates. Novavax NVAX was in focus this week as investors were disappointed with the lowered guidance.Novavax incurred a third-quarter 2024 loss of 76 cents per share, narrower than the Zacks Consensus Estimate of a loss of 87 cents. In the year-ago quarter, the company reported a loss of $1.26 per share.Revenues in the quarter amounted to $85 million, which beat the Zacks Consensus Estimate of $57 million. However, the top line declined 55% on a year-over-year basis.Novavax also announced that the FDA has lifted the clinical hold on its two pipeline programs, COVID-19-Influenza Combination  and stand-alone influenza vaccine candidates. The agency had initially placed this hold after a study participant who took the CIC shot as part of a phase II study reported nerve damage. With this hold removed, management is working with study investigators and other partner","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/vtsVt8PEmb10KQ4cnwEJfQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/96776645e0ac7ab203b7d5e3b37251a6","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/vtsVt8PEmb10KQ4cnwEJfQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/96776645e0ac7ab203b7d5e3b37251a6"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotech-stock-roundup-nvax-q3-191600128.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4547","BK4139","BK4161","SNDX","BK4585","RNA","CR","BK4588","BK4568","NVAX","BK4505"],"gpt_icon":0},{"id":"2483280042","title":"RNA Stock Hits Record High on Entering the Cardiac Disease Space","url":"https://stock-news.laohu8.com/highlight/detail?id=2483280042","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483280042?lang=en_us&edition=fundamental","pubTime":"2024-11-14 21:36","pubTimestamp":1731591360,"startTime":"0","endTime":"0","summary":"Shares of Avidity Biosciences RNA rose more than 12% on Wednesday after the company announced that it is expanding its current RNA-based pipeline of rare muscle disordersto explore a new therapeutic area — precision cardiology.Avidity Enters the Cardio Space With Two New Drugs. The company has decided to advance two new wholly-owned pipeline drugs, AOC 1086 and AOC 1072, targeting two rare genetic cardiomyopathies, PLN cardiomyopathy and PRKAG2 syndrome, respectively.There is currently no FDA-approved therapy for PLN cardiomyopathy and PRKAG2 syndrome, which are caused by mutations in the PLN and PRKAG2 genes, respectively. An excess build-up of these genes can lead to arrhythmias, sudden cardiac arrest, heart failure and other complications.Per management, both AOC 1086 and AOC 1072 have been designed to address the root causes of the genetic diseases. Based on preclinical studies conducted by Avidity, both drugs have demonstrated robust delivery of siRNA  against targets in the heart","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/B7EfA6ERTo_QO90H15uyXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/B7EfA6ERTo_QO90H15uyXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rna-stock-hits-record-high-133600089.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BIIB","CSTL","BK4532","LU0234570918.USD","IE00B894F039.SGD","BK4196","BK4533","BK4139","LU0109394709.USD","IE00B19Z9Z06.USD","LU0320765992.SGD","RNA","IE00B19Z9P08.USD","BK4505","LU0889565916.HKD","BK4588"],"gpt_icon":0},{"id":"2483071512","title":"Avidity Biosciences (RNA) Gets a Buy from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2483071512","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483071512?lang=en_us&edition=fundamental","pubTime":"2024-11-13 18:16","pubTimestamp":1731493006,"startTime":"0","endTime":"0","summary":"Barclays analyst Gena Wang maintained a Buy rating on Avidity Biosciences (RNA – Research Report) today and set a price target of $63.00. The compa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/avidity-biosciences-rna-gets-a-buy-from-barclays?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/avidity-biosciences-rna-gets-a-buy-from-barclays?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","BK4139","BK4585","RNA","BK4588"],"gpt_icon":0},{"id":"2483707964","title":"Avidity Biosciences Price Target Maintained With a $60.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2483707964","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483707964?lang=en_us&edition=fundamental","pubTime":"2024-11-13 18:07","pubTimestamp":1731492420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RNA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 13, 2024 05:07 ET (10:07 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNA"],"gpt_icon":0},{"id":"2483025046","title":"Promising Outlook for Avidity Biosciences: Strategic Focus on Genetic Targeting and Innovative AOC Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2483025046","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483025046?lang=en_us&edition=fundamental","pubTime":"2024-11-13 15:35","pubTimestamp":1731483310,"startTime":"0","endTime":"0","summary":"In a report released today, Keay Nakae from Chardan Capital reiterated a Buy rating on Avidity Biosciences (RNA – Research Report), with a price ta...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/promising-outlook-for-avidity-biosciences-strategic-focus-on-genetic-targeting-and-innovative-aoc-technology?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/promising-outlook-for-avidity-biosciences-strategic-focus-on-genetic-targeting-and-innovative-aoc-technology?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4585","BK4139","BK4505","BK4588","GENE","RNA"],"gpt_icon":0},{"id":"2483093463","title":"PYC Therapeutics to Unveil Pioneering RNA Therapy Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2483093463","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483093463?lang=en_us&edition=fundamental","pubTime":"2024-11-13 08:19","pubTimestamp":1731457172,"startTime":"0","endTime":"0","summary":"PYC Therapeutics Limited (AU:PYC) has released an update. PYC Therapeutics, a clinical-stage biotech firm focused on RNA therapies, is poised to re...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pyc-therapeutics-to-unveil-pioneering-rna-therapy-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pyc-therapeutics-to-unveil-pioneering-rna-therapy-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNA","BK4505","BK4585","BK4588","BK4139","LENZ"],"gpt_icon":0},{"id":"2483053778","title":"Buy Rating Affirmed for Avidity Biosciences Amid Precision Cardiology Advancements","url":"https://stock-news.laohu8.com/highlight/detail?id=2483053778","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483053778?lang=en_us&edition=fundamental","pubTime":"2024-11-13 03:25","pubTimestamp":1731439511,"startTime":"0","endTime":"0","summary":"In a report released today, Joseph Stringer from Needham maintained a Buy rating on Avidity Biosciences (RNA – Research Report), with a price targe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/buy-rating-affirmed-for-avidity-biosciences-amid-precision-cardiology-advancements?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/buy-rating-affirmed-for-avidity-biosciences-amid-precision-cardiology-advancements?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNA"],"gpt_icon":0},{"id":"2482815703","title":"Avidity Biosciences Announces New Precision Cardiology Development Candidates to Treat Rare Genetic Cardiomyopathies and Provides First Look at Next-Generation Technology Innovations","url":"https://stock-news.laohu8.com/highlight/detail?id=2482815703","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482815703?lang=en_us&edition=fundamental","pubTime":"2024-11-12 20:00","pubTimestamp":1731412800,"startTime":"0","endTime":"0","summary":"Avidity expandsits leading RNA delivery technology into precision cardiology with two new wholly-owned development candidates targeting rare genetic cardiomyopathies: AOC 1086 to treat PLN Cardiomyopathy and AOC 1072 to treat PRKAG2 Syndrome. AOC 1072 and AOC 1086 preclinical data demonstrated robust siRNA delivery to the heart and targeted knockdown with potent reduction of approximately 80% in cardiac PLN mRNA and PRKAG2 mRNA. Avidity introduces next-generation technology innovations demonstrating improvedsiRNA delivery in skeletal muscle and increased durability in preclinical studies. AOC 1072 preclinical data will be presented at American Heart Association  Scientific Sessions 2024. AOC 1072 and AOC 1086 are designed to deliver siRNA directly to the heart muscle to knock down specific disease-causing genetic mutations that cause rare genetic cardiomyopathies. In preclinical studies, AOC 1086 and AOC 1072 demonstrated robust siRNA delivery to the heart muscle andpotent targeted kno","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MPQ_41DhqhHuW4qoOGYzoA--~B/aD0xODg7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/d3ba411dafc5b9fe6b77b592275c9c79","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MPQ_41DhqhHuW4qoOGYzoA--~B/aD0xODg7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/d3ba411dafc5b9fe6b77b592275c9c79"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/avidity-biosciences-announces-precision-cardiology-120000385.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/avidity-biosciences-announces-precision-cardiology-120000385.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","BK4139","RNA","BK4585","BK4121","ICD","BK4092","GENE","BK4505"],"gpt_icon":0},{"id":"2482765621","title":"Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2482765621","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482765621?lang=en_us&edition=fundamental","pubTime":"2024-11-12 05:05","pubTimestamp":1731359100,"startTime":"0","endTime":"0","summary":"—Spotlight Presentation to showcase four routes of synthesis of an approved siRNA therapeutic asset— —Joint poster presentation with Bachem to compare Codexis double-stranded RNA ligase to wild-type e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/11/2978579/24825/en/Codexis-TIDES-Europe-Presentations-to-Feature-Next-Step-in-Evolution-of-Enzymatic-Synthesis-for-RNAi-Therapeutics.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","BK4144","ECO","EPM","BK4585","LENZ","CET","BK4505","BK4139","CDXS","BK4588","LU0997586861.USD","BK4121","RNA"],"gpt_icon":0},{"id":"2482078425","title":"Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2482078425","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482078425?lang=en_us&edition=fundamental","pubTime":"2024-11-11 21:30","pubTimestamp":1731331800,"startTime":"0","endTime":"0","summary":"CHICAGO, November 11, 2024----Tempus AI, Inc. , a technology company leading the adoption of AI to advance precision medicine and patient care, today announced publication of its study, \"Actionable structural variant detection via RNA-NGS and DNA-NGS in patients with advanced non-small cell lung cancer,\" in JAMA Network Open.\"This large study underscores the importance of using both RNA- and DNA-based comprehensive genomic profiling as a standard of care in advanced NSCLC, and more broadly in solid tumors,\" said Halla Nimeiri, MD, Chief Development Officer at Tempus. \"By integrating RNA and DNA sequencing, we can detect a wider range of actionable alterations that might otherwise go undetected by DNA testing alone. This combined approach enhances clinicians' ability to provide more personalized treatment options for patients.\"","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/xFb4bpUMLbv.i5Lu1OtM_w--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/cc017a623bfa90c00b474f5692bf3306","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/xFb4bpUMLbv.i5Lu1OtM_w--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/cc017a623bfa90c00b474f5692bf3306"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tempus-publishes-study-highlighting-benefits-133000970.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4121","BK4585","BK4139","BK4505","DNA","IE00B19Z4B17.USD","IE00B66KJ199.SGD","BK4109","BK4157","BK4588","IE00B7SZL793.SGD","NGS","IE0031619046.USD","AEIS","BK4179","RNA","TEM"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RNA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-27","symbol":"RNA","fiscalQuarterEnding":"2024/12","expectedEps":-0.84,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"post","actualEps":-0.8},{"market":"US","date":"2024-11-07","symbol":"RNA","fiscalQuarterEnding":"2024/09","expectedEps":-0.79,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.65},{"market":"US","date":"2024-08-09","symbol":"RNA","fiscalQuarterEnding":"2024/06","expectedEps":-0.76,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"post","actualEps":-0.65},{"market":"US","date":"2024-05-09","symbol":"RNA","fiscalQuarterEnding":"2024/03","expectedEps":-0.81,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-0.79},{"market":"US","date":"2024-02-28","symbol":"RNA","fiscalQuarterEnding":"2023/12","expectedEps":-0.54,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1709096400000,"reportTimeType":"post","actualEps":-0.79}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RNA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RNA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1538,"buy":0.8462,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8462,"analysts":13,"updateTime":1742443200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RNA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RNA","date":"2025-04-14","current":-9.540836,"percent":0.552013,"low":-41.796609,"twenty":-20.551246,"median":-11.128576,"eighty":-5.018968,"high":-1.864956,"avg":-13.175454,"sd":9.288453,"marketCap":3075030659},"quantilePoints":[{"date":"2020-06-12","current":-35.638406,"twenty":-29.775182,"median":-20.980345,"eighty":-20.980345,"marketCap":1007497743},{"date":"2020-06-19","current":-39.899176,"twenty":-39.116319,"median":-35.96886,"eighty":-26.843569,"marketCap":1127949695},{"date":"2020-06-26","current":-35.321452,"twenty":-39.755873,"median":-37.152541,"eighty":-35.448234,"marketCap":998537442},{"date":"2020-07-02","current":-35.653171,"twenty":-39.328619,"median":-36.138594,"eighty":-35.384843,"marketCap":1007915142},{"date":"2020-07-10","current":-35.746052,"twenty":-38.41042,"median":-36.382953,"eighty":-35.641359,"marketCap":1010540898},{"date":"2020-07-17","current":-34.352832,"twenty":-38.00705,"median":-36.138594,"eighty":-35.045462,"marketCap":971154560},{"date":"2020-07-24","current":-31.486779,"twenty":-37.457723,"median":-35.838933,"eighty":-32.192677,"marketCap":890131236},{"date":"2020-07-31","current":-37.404648,"twenty":-37.478953,"median":-36.117578,"eighty":-33.328484,"marketCap":1057429395},{"date":"2020-08-07","current":-38.121161,"twenty":-37.815979,"median":-36.147989,"eighty":-33.816774,"marketCap":1077685226},{"date":"2020-08-14","current":-32.261103,"twenty":-37.539989,"median":-35.87874,"eighty":-32.619559,"marketCap":1087521766},{"date":"2020-08-21","current":-33.897535,"twenty":-37.478953,"median":-35.772589,"eighty":-32.619559,"marketCap":1142685913},{"date":"2020-08-28","current":-31.749022,"twenty":-37.383418,"median":-35.638406,"eighty":-31.8314,"marketCap":1070259516},{"date":"2020-09-04","current":-31.949401,"twenty":-37.295844,"median":-35.095883,"eighty":-31.869249,"marketCap":1077014309},{"date":"2020-09-11","current":-37.281723,"twenty":-37.285229,"median":-35.268377,"eighty":-31.949401,"marketCap":1256766872},{"date":"2020-09-18","current":-38.194563,"twenty":-37.497529,"median":-35.653171,"eighty":-32.060723,"marketCap":1287538709},{"date":"2020-09-25","current":-32.45035,"twenty":-37.497529,"median":-35.645789,"eighty":-32.160913,"marketCap":1093901293},{"date":"2020-10-02","current":-31.860343,"twenty":-37.404648,"median":-35.215302,"eighty":-31.949401,"marketCap":1074012179},{"date":"2020-10-09","current":-30.802785,"twenty":-37.298498,"median":-34.503678,"eighty":-31.871476,"marketCap":1038361879},{"date":"2020-10-16","current":-31.726757,"twenty":-37.285229,"median":-33.897535,"eighty":-31.826947,"marketCap":1069508983},{"date":"2020-10-23","current":-31.125619,"twenty":-37.281723,"median":-33.665444,"eighty":-31.749022,"marketCap":1049244602},{"date":"2020-10-30","current":-27.529919,"twenty":-37.16581,"median":-33.313095,"eighty":-31.613224,"marketCap":928033584},{"date":"2020-11-06","current":-31.147883,"twenty":-37.152541,"median":-33.245062,"eighty":-31.420435,"marketCap":1049995135},{"date":"2020-11-13","current":-28.475809,"twenty":-37.148136,"median":-33.185075,"eighty":-31.147883,"marketCap":1095777625},{"date":"2020-11-20","current":-28.924401,"twenty":-37.112735,"median":-32.711956,"eighty":-30.969768,"marketCap":1113039875},{"date":"2020-11-27","current":-29.967864,"twenty":-36.97474,"median":-32.628465,"eighty":-30.631349,"marketCap":1153193370},{"date":"2020-12-04","current":-31.71347,"twenty":-36.937348,"median":-32.283367,"eighty":-30.353044,"marketCap":1220366040},{"date":"2020-12-11","current":-31.37215,"twenty":-36.722887,"median":-32.366858,"eighty":-30.408705,"marketCap":1207231719},{"date":"2020-12-18","current":-28.007714,"twenty":-36.620708,"median":-32.261103,"eighty":-30.184146,"marketCap":1077764842},{"date":"2020-12-24","current":-28.778121,"twenty":-36.497064,"median":-32.160913,"eighty":-30.079555,"marketCap":1107410880},{"date":"2020-12-31","current":-24.887077,"twenty":-36.316609,"median":-32.105252,"eighty":-29.407768,"marketCap":957679623},{"date":"2021-01-08","current":-27.451851,"twenty":-36.149868,"median":-32.005062,"eighty":-29.207279,"marketCap":1056374662},{"date":"2021-01-15","current":-25.803764,"twenty":-36.130188,"median":-31.860343,"eighty":-29.125292,"marketCap":992954656},{"date":"2021-01-22","current":-25.238149,"twenty":-36.089914,"median":-31.826947,"eighty":-28.936103,"marketCap":971189210},{"date":"2021-01-29","current":-22.312552,"twenty":-35.97035,"median":-31.754588,"eighty":-28.475809,"marketCap":858609317},{"date":"2021-02-05","current":-21.883465,"twenty":-35.92353,"median":-31.737889,"eighty":-28.025268,"marketCap":842097599},{"date":"2021-02-12","current":-21.727433,"twenty":-35.862817,"median":-31.708982,"eighty":-27.465504,"marketCap":836093338},{"date":"2021-02-19","current":-25.228397,"twenty":-35.799127,"median":-31.653595,"eighty":-26.778963,"marketCap":970813943},{"date":"2021-02-26","current":-23.531551,"twenty":-35.746052,"median":-31.486779,"eighty":-26.086572,"marketCap":905517606},{"date":"2021-03-05","current":-22.390568,"twenty":-35.653171,"median":-31.396293,"eighty":-25.940292,"marketCap":861611447},{"date":"2021-03-12","current":-25.004101,"twenty":-35.638406,"median":-31.225808,"eighty":-25.238149,"marketCap":962182818},{"date":"2021-03-19","current":-21.412757,"twenty":-35.321452,"median":-31.064391,"eighty":-25.004101,"marketCap":949762842},{"date":"2021-03-26","current":-17.828429,"twenty":-35.215302,"median":-30.969768,"eighty":-24.887077,"marketCap":790779984},{"date":"2021-04-01","current":-18.989311,"twenty":-35.024232,"median":-30.680331,"eighty":-24.762252,"marketCap":842270886},{"date":"2021-04-09","current":-18.72663,"twenty":-34.718913,"median":-30.446554,"eighty":-23.687583,"marketCap":830619660},{"date":"2021-04-16","current":-17.582695,"twenty":-34.413171,"median":-30.201646,"eighty":-23.329342,"marketCap":779880450},{"date":"2021-04-23","current":-19.048626,"twenty":-34.331602,"median":-30.09464,"eighty":-22.642588,"marketCap":844901808},{"date":"2021-04-30","current":-19.878228,"twenty":-34.264448,"median":-29.967864,"eighty":-22.388618,"marketCap":881698811},{"date":"2021-05-07","current":-18.504392,"twenty":-33.967825,"median":-29.319357,"eighty":-21.984885,"marketCap":820762289},{"date":"2021-05-14","current":-12.366031,"twenty":-33.808477,"median":-29.222013,"eighty":-21.780094,"marketCap":768103629},{"date":"2021-05-21","current":-13.322854,"twenty":-33.708758,"median":-29.156835,"eighty":-21.678673,"marketCap":827535742},{"date":"2021-05-28","current":-14.37657,"twenty":-33.651075,"median":-29.109689,"eighty":-21.248369,"marketCap":892986296},{"date":"2021-06-04","current":-13.528752,"twenty":-33.48787,"median":-28.982913,"eighty":-20.919439,"marketCap":840324930},{"date":"2021-06-11","current":-15.533236,"twenty":-33.342039,"median":-28.773245,"eighty":-20.304412,"marketCap":964831444},{"date":"2021-06-18","current":-16.235714,"twenty":-33.276359,"median":-28.475809,"eighty":-19.944808,"marketCap":1008465147},{"date":"2021-06-25","current":-17.719396,"twenty":-33.251868,"median":-28.20763,"eighty":-18.985306,"marketCap":1100622536},{"date":"2021-07-02","current":-14.3039,"twenty":-33.243701,"median":-27.69565,"eighty":-18.607999,"marketCap":888472464},{"date":"2021-07-09","current":-15.266779,"twenty":-33.225889,"median":-27.520114,"eighty":-18.486902,"marketCap":948280729},{"date":"2021-07-16","current":-13.777042,"twenty":-33.198433,"median":-27.183671,"eighty":-17.913165,"marketCap":855747187},{"date":"2021-07-23","current":-13.316798,"twenty":-33.073753,"median":-26.730203,"eighty":-17.637375,"marketCap":827159589},{"date":"2021-07-30","current":-11.693832,"twenty":-32.854637,"median":-26.218224,"eighty":-17.10309,"marketCap":726350689},{"date":"2021-08-06","current":-14.746344,"twenty":-32.752871,"median":-26.067068,"eighty":-16.259938,"marketCap":915954440},{"date":"2021-08-13","current":-11.436404,"twenty":-32.71307,"median":-25.872028,"eighty":-15.828761,"marketCap":891021641},{"date":"2021-08-20","current":-11.81156,"twenty":-32.688579,"median":-25.374677,"eighty":-15.39153,"marketCap":920250439},{"date":"2021-08-27","current":-11.881902,"twenty":-32.635144,"median":-25.223521,"eighty":-15.121439,"marketCap":925730839},{"date":"2021-09-03","current":-11.278135,"twenty":-32.554492,"median":-25.004101,"eighty":-14.763154,"marketCap":878690742},{"date":"2021-09-10","current":-13.224258,"twenty":-32.484973,"median":-24.974845,"eighty":-14.543711,"marketCap":1030315132},{"date":"2021-09-17","current":-14.044912,"twenty":-32.416953,"median":-24.862697,"eighty":-14.441383,"marketCap":1094253128},{"date":"2021-09-24","current":-13.734236,"twenty":-32.283367,"median":-24.779805,"eighty":-14.366881,"marketCap":1070048029},{"date":"2021-10-01","current":-13.611137,"twenty":-32.278914,"median":-24.024026,"eighty":-14.14795,"marketCap":1060457330},{"date":"2021-10-08","current":-13.441145,"twenty":-32.243291,"median":-23.531551,"eighty":-14.069443,"marketCap":1047213031},{"date":"2021-10-15","current":-12.614629,"twenty":-32.169819,"median":-23.441741,"eighty":-13.946434,"marketCap":982818335},{"date":"2021-10-22","current":-13.001509,"twenty":-32.160913,"median":-22.956183,"eighty":-13.742797,"marketCap":1012960533},{"date":"2021-10-29","current":-13.189087,"twenty":-32.149781,"median":-22.581778,"eighty":-13.630951,"marketCap":1027574932},{"date":"2021-11-05","current":-15.299341,"twenty":-32.09711,"median":-22.410072,"eighty":-13.655687,"marketCap":1191986921},{"date":"2021-11-12","current":-12.166812,"twenty":-32.063778,"median":-22.346684,"eighty":-13.593676,"marketCap":1164923541},{"date":"2021-11-19","current":-13.7195,"twenty":-32.038459,"median":-22.01024,"eighty":-13.566299,"marketCap":1313587294},{"date":"2021-11-26","current":-11.863131,"twenty":-31.949401,"median":-21.834705,"eighty":-13.499763,"marketCap":1135847350},{"date":"2021-12-03","current":-11.363528,"twenty":-31.871476,"median":-21.771317,"eighty":-13.400112,"marketCap":1088012325},{"date":"2021-12-10","current":-11.936602,"twenty":-31.860343,"median":-21.688425,"eighty":-13.322854,"marketCap":1142881912},{"date":"2021-12-17","current":-11.363528,"twenty":-31.849211,"median":-21.545715,"eighty":-13.25624,"marketCap":1088012325},{"date":"2021-12-23","current":-12.543963,"twenty":-31.8314,"median":-21.349205,"eighty":-13.175019,"marketCap":1201034295},{"date":"2021-12-31","current":-11.642718,"twenty":-31.820188,"median":-20.980345,"eighty":-13.050829,"marketCap":1114743662},{"date":"2022-01-07","current":-9.389605,"twenty":-31.771823,"median":-20.760217,"eighty":-12.953442,"marketCap":899017081},{"date":"2022-01-14","current":-8.733263,"twenty":-31.751248,"median":-20.311191,"eighty":-12.90702,"marketCap":836174989},{"date":"2022-01-21","current":-6.965059,"twenty":-31.742342,"median":-20.064799,"eighty":-12.792452,"marketCap":666876520},{"date":"2022-01-28","current":-7.464662,"twenty":-31.737889,"median":-19.933711,"eighty":-12.673256,"marketCap":714711544},{"date":"2022-02-04","current":-7.969164,"twenty":-31.73121,"median":-19.0217,"eighty":-12.607595,"marketCap":763015540},{"date":"2022-02-11","current":-7.85161,"twenty":-31.718785,"median":-18.924175,"eighty":-12.532803,"marketCap":751760240},{"date":"2022-02-18","current":-7.312822,"twenty":-31.708084,"median":-18.658841,"eighty":-12.451927,"marketCap":700173449},{"date":"2022-02-25","current":-8.013246,"twenty":-31.700282,"median":-18.504392,"eighty":-12.34642,"marketCap":767236277},{"date":"2022-03-04","current":-6.42211,"twenty":-31.661669,"median":-18.41632,"eighty":-12.182486,"marketCap":757866723},{"date":"2022-03-11","current":-7.093861,"twenty":-31.575306,"median":-18.040269,"eighty":-12.09334,"marketCap":837139487},{"date":"2022-03-18","current":-7.478298,"twenty":-31.50577,"median":-17.752167,"eighty":-11.945203,"marketCap":882506430},{"date":"2022-03-25","current":-7.004834,"twenty":-31.476164,"median":-17.582695,"eighty":-11.873443,"marketCap":826633458},{"date":"2022-04-01","current":-8.097442,"twenty":-31.444319,"median":-17.294593,"eighty":-11.825906,"marketCap":955571086},{"date":"2022-04-08","current":-7.988182,"twenty":-31.401121,"median":-16.853967,"eighty":-11.719268,"marketCap":942677323},{"date":"2022-04-14","current":-7.373084,"twenty":-31.365146,"median":-16.296273,"eighty":-11.643698,"marketCap":870090214},{"date":"2022-04-22","current":-6.745845,"twenty":-31.314866,"median":-16.08129,"eighty":-11.54955,"marketCap":796070465},{"date":"2022-04-29","current":-6.030185,"twenty":-31.210223,"median":-15.799693,"eighty":-11.378103,"marketCap":711616090},{"date":"2022-05-06","current":-5.726567,"twenty":-31.14343,"median":-15.63013,"eighty":-11.319167,"marketCap":675786469},{"date":"2022-05-13","current":-5.018968,"twenty":-31.101128,"median":-15.299341,"eighty":-11.132571,"marketCap":644435550},{"date":"2022-05-20","current":-5.018968,"twenty":-30.999044,"median":-15.266779,"eighty":-10.917803,"marketCap":644435550},{"date":"2022-05-27","current":-5.670078,"twenty":-30.980006,"median":-15.085104,"eighty":-10.201035,"marketCap":728038000},{"date":"2022-06-03","current":-5.080979,"twenty":-30.969768,"median":-14.994266,"eighty":-9.134905,"marketCap":652397688},{"date":"2022-06-10","current":-4.918202,"twenty":-30.802785,"median":-14.767356,"eighty":-8.321825,"marketCap":631497076},{"date":"2022-06-17","current":-4.976336,"twenty":-30.680331,"median":-14.582469,"eighty":-8.263048,"marketCap":638961580},{"date":"2022-06-24","current":-5.511176,"twenty":-30.671425,"median":-14.503743,"eighty":-8.133739,"marketCap":707635021},{"date":"2022-07-01","current":-5.991757,"twenty":-30.517801,"median":-14.446601,"eighty":-8.061832,"marketCap":769341591},{"date":"2022-07-08","current":-6.615737,"twenty":-30.439875,"median":-14.434107,"eighty":-8.00322,"marketCap":849460606},{"date":"2022-07-15","current":-6.794017,"twenty":-30.3998,"median":-14.37657,"eighty":-7.922142,"marketCap":872351753},{"date":"2022-07-22","current":-6.418079,"twenty":-30.277345,"median":-14.265264,"eighty":-7.829079,"marketCap":824081291},{"date":"2022-07-29","current":-6.313436,"twenty":-30.149145,"median":-14.128281,"eighty":-7.661565,"marketCap":810645183},{"date":"2022-08-05","current":-7.359862,"twenty":-30.102442,"median":-14.079861,"eighty":-7.498145,"marketCap":945006263},{"date":"2022-08-12","current":-7.744765,"twenty":-30.09464,"median":-14.061667,"eighty":-7.476679,"marketCap":1144188352},{"date":"2022-08-19","current":-7.3884,"twenty":-30.072013,"median":-14.02967,"eighty":-7.470415,"marketCap":1091540050},{"date":"2022-08-26","current":-7.741237,"twenty":-30.00349,"median":-13.904228,"eighty":-7.470415,"marketCap":1143667082},{"date":"2022-09-02","current":-7.501308,"twenty":-29.680657,"median":-13.816405,"eighty":-7.464662,"marketCap":1108220700},{"date":"2022-09-09","current":-7.363701,"twenty":-29.434907,"median":-13.754752,"eighty":-7.442192,"marketCap":1087891157},{"date":"2022-09-16","current":-7.349588,"twenty":-29.326183,"median":-13.669756,"eighty":-7.391986,"marketCap":1085806076},{"date":"2022-09-23","current":-6.541592,"twenty":-29.285225,"median":-13.638908,"eighty":-7.361398,"marketCap":966435173},{"date":"2022-09-30","current":-5.761823,"twenty":-29.25994,"median":-13.589311,"eighty":-7.336663,"marketCap":851234432},{"date":"2022-10-07","current":-5.779465,"twenty":-29.212191,"median":-13.561735,"eighty":-7.29548,"marketCap":853840784},{"date":"2022-10-14","current":-5.79005,"twenty":-29.181854,"median":-13.499763,"eighty":-7.22525,"marketCap":855404595},{"date":"2022-10-21","current":-5.020866,"twenty":-29.157157,"median":-13.418819,"eighty":-7.180208,"marketCap":741767665},{"date":"2022-10-28","current":-5.130245,"twenty":-29.152611,"median":-13.388388,"eighty":-7.120264,"marketCap":757927045},{"date":"2022-11-04","current":-4.784465,"twenty":-29.133094,"median":-13.325882,"eighty":-7.077936,"marketCap":706842553},{"date":"2022-11-11","current":-4.987127,"twenty":-29.082383,"median":-13.286519,"eighty":-7.007322,"marketCap":808223767},{"date":"2022-11-18","current":-4.076405,"twenty":-29.01802,"median":-13.240249,"eighty":-6.959181,"marketCap":660630343},{"date":"2022-11-25","current":-4.210829,"twenty":-28.971211,"median":-13.206672,"eighty":-6.908542,"marketCap":682415350},{"date":"2022-12-02","current":-3.908375,"twenty":-28.895145,"median":-13.107021,"eighty":-6.819609,"marketCap":633399084},{"date":"2022-12-09","current":-3.666412,"twenty":-28.776171,"median":-13.032334,"eighty":-6.759911,"marketCap":594186071},{"date":"2022-12-16","current":-7.552337,"twenty":-28.709857,"median":-12.972199,"eighty":-6.729659,"marketCap":1223946832},{"date":"2022-12-23","current":-8.569155,"twenty":-28.475809,"median":-12.939832,"eighty":-6.746629,"marketCap":1388734462},{"date":"2022-12-30","current":-9.098065,"twenty":-28.475809,"median":-12.916512,"eighty":-6.749766,"marketCap":1474450608},{"date":"2023-01-06","current":-8.130447,"twenty":-28.468007,"median":-12.870801,"eighty":-6.757262,"marketCap":1317636573},{"date":"2023-01-13","current":-9.286668,"twenty":-28.349034,"median":-12.790483,"eighty":-6.762237,"marketCap":1505016056},{"date":"2023-01-20","current":-9.212867,"twenty":-28.1852,"median":-12.679109,"eighty":-6.781615,"marketCap":1493055663},{"date":"2023-01-27","current":-9.622875,"twenty":-28.042821,"median":-12.668823,"eighty":-6.805644,"marketCap":1559502288},{"date":"2023-02-03","current":-9.90988,"twenty":-27.820476,"median":-12.614629,"eighty":-6.815441,"marketCap":1606014926},{"date":"2023-02-10","current":-9.319469,"twenty":-27.596211,"median":-12.557946,"eighty":-6.825218,"marketCap":1510331786},{"date":"2023-02-17","current":-10.516691,"twenty":-27.524036,"median":-12.524371,"eighty":-6.862225,"marketCap":1704355931},{"date":"2023-02-24","current":-9.335869,"twenty":-27.492809,"median":-12.493203,"eighty":-6.889742,"marketCap":1512989651},{"date":"2023-03-03","current":-10.035487,"twenty":-27.440149,"median":-12.425244,"eighty":-6.901778,"marketCap":1746124614},{"date":"2023-03-10","current":-8.354767,"twenty":-27.231456,"median":-12.333346,"eighty":-6.912071,"marketCap":1453687685},{"date":"2023-03-17","current":-8.346628,"twenty":-26.878433,"median":-12.20808,"eighty":-6.923154,"marketCap":1452271526},{"date":"2023-03-24","current":-8.15129,"twenty":-26.759459,"median":-12.160132,"eighty":-6.936445,"marketCap":1418283699},{"date":"2023-03-31","current":-6.246745,"twenty":-26.718501,"median":-12.09334,"eighty":-6.923154,"marketCap":1086902385},{"date":"2023-04-06","current":-5.514228,"twenty":-26.630733,"median":-12.022319,"eighty":-6.88645,"marketCap":959448034},{"date":"2023-04-14","current":-6.210119,"twenty":-26.297215,"median":-11.936602,"eighty":-6.814077,"marketCap":1080529667},{"date":"2023-04-21","current":-6.409527,"twenty":-26.086572,"median":-11.881733,"eighty":-6.75164,"marketCap":1115225574},{"date":"2023-04-28","current":-5.921182,"twenty":-26.082671,"median":-11.863131,"eighty":-6.746629,"marketCap":1030256007},{"date":"2023-05-05","current":-4.55822,"twenty":-26.057316,"median":-11.826396,"eighty":-6.654268,"marketCap":793107504},{"date":"2023-05-12","current":-4.123772,"twenty":-26.002705,"median":-11.770068,"eighty":-6.61586,"marketCap":792399372},{"date":"2023-05-19","current":-3.939845,"twenty":-25.912986,"median":-11.705944,"eighty":-6.582075,"marketCap":757056927},{"date":"2023-05-26","current":-4.028298,"twenty":-25.768657,"median":-11.642718,"eighty":-6.532696,"marketCap":774053528},{"date":"2023-06-02","current":-4.006185,"twenty":-25.628229,"median":-11.606396,"eighty":-6.507219,"marketCap":769804377},{"date":"2023-06-09","current":-4.38211,"twenty":-25.425387,"median":-11.536054,"eighty":-6.447533,"marketCap":842039931},{"date":"2023-06-16","current":-4.599557,"twenty":-25.265455,"median":-11.451058,"eighty":-6.417304,"marketCap":883823241},{"date":"2023-06-23","current":-4.297342,"twenty":-25.232298,"median":-11.363528,"eighty":-6.355731,"marketCap":825751522},{"date":"2023-06-30","current":-4.087266,"twenty":-25.224496,"median":-11.343275,"eighty":-6.280747,"marketCap":785384595},{"date":"2023-07-07","current":-3.973015,"twenty":-25.19329,"median":-11.29572,"eighty":-6.217444,"marketCap":763430652},{"date":"2023-07-14","current":-4.083581,"twenty":-25.074315,"median":-11.149175,"eighty":-6.034901,"marketCap":784676403},{"date":"2023-07-21","current":-3.718712,"twenty":-25.0002,"median":-11.00556,"eighty":-5.918732,"marketCap":714565425},{"date":"2023-07-28","current":-3.353844,"twenty":-24.982647,"median":-10.912905,"eighty":-5.893783,"marketCap":644454447},{"date":"2023-08-04","current":-3.449668,"twenty":-24.963143,"median":-10.690816,"eighty":-5.812632,"marketCap":662867431},{"date":"2023-08-11","current":-3.431213,"twenty":-24.910482,"median":-10.45519,"eighty":-5.790085,"marketCap":663902014},{"date":"2023-08-18","current":-3.15932,"twenty":-24.877325,"median":-10.098356,"eighty":-5.73622,"marketCap":611293707},{"date":"2023-08-25","current":-3.036777,"twenty":-24.830515,"median":-9.963181,"eighty":-5.694292,"marketCap":587582921},{"date":"2023-09-01","current":-2.895086,"twenty":-24.795408,"median":-9.92423,"eighty":-5.645386,"marketCap":560167324},{"date":"2023-09-08","current":-2.657658,"twenty":-24.779805,"median":-9.89937,"eighty":-5.620688,"marketCap":514227676},{"date":"2023-09-15","current":-2.79169,"twenty":-24.692038,"median":-9.799178,"eighty":-5.507781,"marketCap":540161349},{"date":"2023-09-22","current":-2.665317,"twenty":-24.321462,"median":-9.686426,"eighty":-5.398782,"marketCap":515709600},{"date":"2023-09-29","current":-2.512138,"twenty":-23.726591,"median":-9.659775,"eighty":-5.29414,"marketCap":486071117},{"date":"2023-10-06","current":-2.385765,"twenty":-23.726591,"median":-9.633125,"eighty":-5.197248,"marketCap":461619369},{"date":"2023-10-13","current":-2.339812,"twenty":-23.531551,"median":-9.508072,"eighty":-5.09849,"marketCap":452727824},{"date":"2023-10-20","current":-2.113872,"twenty":-23.531551,"median":-9.377088,"eighty":-5.020866,"marketCap":409011062},{"date":"2023-10-27","current":-2.021965,"twenty":-23.52765,"median":-9.35022,"eighty":-5.018968,"marketCap":391227972},{"date":"2023-11-03","current":-1.937716,"twenty":-23.457752,"median":-9.319469,"eighty":-4.995462,"marketCap":374926807},{"date":"2023-11-10","current":-2.007807,"twenty":-23.297002,"median":-9.252089,"eighty":-4.97662,"marketCap":406074871},{"date":"2023-11-17","current":-2.172681,"twenty":-23.102463,"median":-9.208767,"eighty":-4.944556,"marketCap":439420436},{"date":"2023-11-24","current":-2.293589,"twenty":-22.944481,"median":-9.098065,"eighty":-4.9058,"marketCap":463873850},{"date":"2023-12-01","current":-2.861491,"twenty":-22.854762,"median":-9.062046,"eighty":-4.817675,"marketCap":578730793},{"date":"2023-12-08","current":-2.949424,"twenty":-22.642588,"median":-9.020164,"eighty":-4.736046,"marketCap":596515094},{"date":"2023-12-15","current":-2.942096,"twenty":-22.478734,"median":-8.888495,"eighty":-4.694967,"marketCap":595033069},{"date":"2023-12-22","current":-3.326804,"twenty":-22.459579,"median":-8.782359,"eighty":-4.625203,"marketCap":672839386},{"date":"2023-12-29","current":-3.418401,"twenty":-22.422449,"median":-8.716971,"eighty":-4.575798,"marketCap":691364699},{"date":"2024-01-05","current":-3.605259,"twenty":-22.40227,"median":-8.619287,"eighty":-4.546011,"marketCap":729156339},{"date":"2024-01-12","current":-4.121866,"twenty":-22.386667,"median":-8.480923,"eighty":-4.474248,"marketCap":833639107},{"date":"2024-01-19","current":-3.821428,"twenty":-22.367163,"median":-8.410527,"eighty":-4.373264,"marketCap":772876079},{"date":"2024-01-26","current":-4.11118,"twenty":-22.291896,"median":-8.346628,"eighty":-4.316264,"marketCap":831478023},{"date":"2024-02-02","current":-4.766927,"twenty":-22.169467,"median":-8.324274,"eighty":-4.333222,"marketCap":964101547},{"date":"2024-02-09","current":-4.912213,"twenty":-21.984885,"median":-8.302651,"eighty":-4.337146,"marketCap":993485202},{"date":"2024-02-16","current":-5.312729,"twenty":-21.873713,"median":-8.279699,"eighty":-4.353363,"marketCap":1074488792},{"date":"2024-02-23","current":-5.709318,"twenty":-21.834705,"median":-8.254149,"eighty":-4.371053,"marketCap":1154698229},{"date":"2024-03-01","current":-6.884704,"twenty":-21.815201,"median":-8.220472,"eighty":-4.38211,"marketCap":1461071871},{"date":"2024-03-08","current":-7.531791,"twenty":-21.785945,"median":-8.189978,"eighty":-4.452135,"marketCap":1598396659},{"date":"2024-03-15","current":-9.017834,"twenty":-21.756689,"median":-8.204249,"eighty":-4.466877,"marketCap":1913764632},{"date":"2024-03-22","current":-9.066741,"twenty":-21.727433,"median":-8.229515,"eighty":-4.485305,"marketCap":1924143831},{"date":"2024-03-28","current":-9.281183,"twenty":-21.696227,"median":-8.254149,"eighty":-4.491202,"marketCap":1969652627},{"date":"2024-04-05","current":-10.661495,"twenty":-21.680623,"median":-8.292436,"eighty":-4.519064,"marketCap":2262582364},{"date":"2024-04-12","current":-11.408564,"twenty":-21.678673,"median":-8.304891,"eighty":-4.535429,"marketCap":2421125493},{"date":"2024-04-19","current":-10.368967,"twenty":-21.46594,"median":-8.326723,"eighty":-4.55415,"marketCap":2200502223},{"date":"2024-04-26","current":-10.7245,"twenty":-21.412757,"median":-8.350698,"eighty":-4.564979,"marketCap":2275953471},{"date":"2024-05-03","current":-11.526166,"twenty":-21.311074,"median":-8.417453,"eighty":-4.569664,"marketCap":2446082844},{"date":"2024-05-10","current":-12.211067,"twenty":-21.136518,"median":-8.528949,"eighty":-4.570559,"marketCap":2591432567},{"date":"2024-05-17","current":-12.011,"twenty":-21.004123,"median":-8.619287,"eighty":-4.575834,"marketCap":2746687402},{"date":"2024-05-24","current":-11.488237,"twenty":-20.980345,"median":-8.728825,"eighty":-4.595074,"marketCap":2627141467},{"date":"2024-05-31","current":-11.316771,"twenty":-20.888986,"median":-8.784409,"eighty":-4.609363,"marketCap":2587930400},{"date":"2024-06-07","current":-10.890196,"twenty":-20.746644,"median":-8.909462,"eighty":-4.626414,"marketCap":2490380917},{"date":"2024-06-14","current":-16.711683,"twenty":-20.65513,"median":-8.938982,"eighty":-4.645017,"marketCap":3821644450},{"date":"2024-06-21","current":-17.463994,"twenty":-20.541673,"median":-9.002785,"eighty":-4.663959,"marketCap":3993683592},{"date":"2024-06-28","current":-18.824523,"twenty":-20.426432,"median":-9.017834,"eighty":-4.66706,"marketCap":4304810763},{"date":"2024-07-05","current":-17.278256,"twenty":-20.304412,"median":-9.028364,"eighty":-4.67213,"marketCap":3951208893},{"date":"2024-07-12","current":-20.575102,"twenty":-20.304412,"median":-9.060735,"eighty":-4.682062,"marketCap":4705134803},{"date":"2024-07-15","current":-20.80263,"twenty":-20.416755,"median":-9.066741,"eighty":-4.685549,"marketCap":4757166310},{"date":"2024-08-02","current":-20.695831,"twenty":-20.57994,"median":-9.068053,"eighty":-4.689037,"marketCap":4732743358},{"date":"2024-08-09","current":-19.442101,"twenty":-20.389364,"median":-9.098065,"eighty":-4.702292,"marketCap":4446039138},{"date":"2024-08-16","current":-21.104668,"twenty":-20.45155,"median":-9.161017,"eighty":-4.704816,"marketCap":5327852349},{"date":"2024-08-23","current":-19.882184,"twenty":-20.693049,"median":-9.212867,"eighty":-4.711267,"marketCap":5019237468},{"date":"2024-08-30","current":-19.782437,"twenty":-20.617905,"median":-9.283926,"eighty":-4.724704,"marketCap":4994056368},{"date":"2024-09-06","current":-18.910228,"twenty":-20.584778,"median":-9.305118,"eighty":-4.728041,"marketCap":4773868141},{"date":"2024-09-13","current":-19.165395,"twenty":-20.528184,"median":-9.335869,"eighty":-4.751474,"marketCap":4838284910},{"date":"2024-09-20","current":-21.178899,"twenty":-20.584778,"median":-9.377088,"eighty":-4.766927,"marketCap":5346591773},{"date":"2024-09-27","current":-19.564385,"twenty":-20.614011,"median":-9.508072,"eighty":-4.767001,"marketCap":4939009311},{"date":"2024-10-04","current":-21.828416,"twenty":-20.69977,"median":-9.611919,"eighty":-4.777499,"marketCap":5510561728},{"date":"2024-10-11","current":-20.515463,"twenty":-20.808388,"median":-9.644811,"eighty":-4.795146,"marketCap":5179108175},{"date":"2024-10-18","current":-22.510409,"twenty":-20.924108,"median":-9.672717,"eighty":-4.8043,"marketCap":5682730182},{"date":"2024-10-25","current":-20.946928,"twenty":-21.062913,"median":-9.717176,"eighty":-4.807671,"marketCap":5288031074},{"date":"2024-10-31","current":-20.051522,"twenty":-21.062913,"median":-9.811478,"eighty":-4.820452,"marketCap":5061986778},{"date":"2024-11-08","current":-19.838416,"twenty":-21.062913,"median":-9.907571,"eighty":-4.84349,"marketCap":5564437571},{"date":"2024-11-15","current":-21.255407,"twenty":-21.084706,"median":-9.93858,"eighty":-4.869368,"marketCap":5961886570},{"date":"2024-11-22","current":-18.103464,"twenty":-21.062913,"median":-9.999334,"eighty":-4.898048,"marketCap":5077804531},{"date":"2024-11-29","current":-18.303385,"twenty":-21.046399,"median":-10.098356,"eighty":-4.902699,"marketCap":5133879910},{"date":"2024-12-06","current":-15.687401,"twenty":-20.980345,"median":-10.127184,"eighty":-4.904602,"marketCap":4400127610},{"date":"2024-12-13","current":-14.360267,"twenty":-20.973662,"median":-10.412078,"eighty":-4.913411,"marketCap":4027882541},{"date":"2024-12-20","current":-13.207532,"twenty":-20.943217,"median":-10.598489,"eighty":-4.922504,"marketCap":3704554292},{"date":"2024-12-27","current":-13.237308,"twenty":-20.928371,"median":-10.661495,"eighty":-4.939713,"marketCap":3712905945},{"date":"2025-01-03","current":-13.262829,"twenty":-20.920948,"median":-10.736574,"eighty":-4.941107,"marketCap":3720064504},{"date":"2025-01-10","current":-12.731125,"twenty":-20.899606,"median":-10.760504,"eighty":-4.946106,"marketCap":3570927857},{"date":"2025-01-17","current":-12.033529,"twenty":-20.875481,"median":-10.849125,"eighty":-4.95057,"marketCap":3375260577},{"date":"2025-01-24","current":-12.816198,"twenty":-20.852067,"median":-10.87291,"eighty":-4.952418,"marketCap":3594789721},{"date":"2025-01-31","current":-13.879606,"twenty":-20.823658,"median":-10.890196,"eighty":-4.960884,"marketCap":3893063013},{"date":"2025-02-07","current":-14.934507,"twenty":-20.811267,"median":-10.956919,"eighty":-4.973416,"marketCap":4188950119},{"date":"2025-02-14","current":-14.045498,"twenty":-20.799109,"median":-11.007295,"eighty":-4.97662,"marketCap":3939593647},{"date":"2025-02-21","current":-13.83707,"twenty":-20.776198,"median":-11.084534,"eighty":-4.979061,"marketCap":3881132082},{"date":"2025-02-28","current":-10.764795,"twenty":-20.703709,"median":-11.126407,"eighty":-4.987294,"marketCap":3469514938},{"date":"2025-03-07","current":-11.319953,"twenty":-20.695136,"median":-11.124394,"eighty":-4.988898,"marketCap":3648443335},{"date":"2025-03-14","current":-11.983857,"twenty":-20.689452,"median":-11.128498,"eighty":-4.99405,"marketCap":3862421231},{"date":"2025-03-21","current":-11.498983,"twenty":-20.669492,"median":-11.149175,"eighty":-5.000402,"marketCap":3706145239},{"date":"2025-03-28","current":-12.144239,"twenty":-20.628729,"median":-11.183518,"eighty":-5.004574,"marketCap":3914112520},{"date":"2025-04-04","current":-10.480747,"twenty":-20.594455,"median":-11.15204,"eighty":-5.011771,"marketCap":3377965658},{"date":"2025-04-11","current":-8.992555,"twenty":-20.563174,"median":-11.12911,"eighty":-5.018968,"marketCap":2898318577},{"date":"2025-04-14","current":-9.540836,"twenty":-20.551246,"median":-11.128576,"eighty":-5.018968,"marketCap":3075030659}],"updateTime":1744725349384}}}